About MicroGenDX
Southwest Regional PCR is a CAP accredited and CLIA licensed clinical diagnostic laboratory doing business as MicroGen Diagnostics, LLC as of April 2017.

Our Journey to bring desperately needed advances in diagnostics to providers and patients

Southwest Regional PCR first began utilizing the combination of both PCR and NGS for identifying microbes in this 2-step process in 2010 under the commercialization name PathoGenius. In 2017, the laboratory was purchased by Rick Martin, the head of commercialization for this testing and rebranded as Southwest Regional PCR dba MicroGenDX. Since rebranding and new leadership was put in place the laboratory has grown in scale and reach to assist physicians, specialties and infection types both nationally and internationally.

Superior Diagnostic Data

MicroGenDX is a molecular diagnostic laboratory that utilizes both Rapid qPCR Screening and Next-Generation DNA Sequencing (NGS) to identify all microbes within a sample taken from the site of infections. Our commitment to delivering the highest level of diagnostic data is why we utilize our 2-Part process of qPCR Rapid screening panel testing and NGS testing that uses our own curated database of 50,000+ bacterial and fungal microbial species. This is in addition to providing 17 antibiotic resistance genes gives physicians a complete and actionable diagnostic data which is essential for treatment decisions. In short, we give physicians the answers they need to provide targeted treatments to patients burdened with tough to treat infections. If your patient is not responding to treatment and culture tests keep coming back negative, ask yourself, “what am I missing and could NGS tell me something I need to know?”

Experience. Knowledge. Process.
Global Leader in NGS Molecular Diagnostics

MicroGenDX laboratory has run over 400,000+ Next Generation DNA Sequencing tests at our state-of-the-art, CAP-accredited, CLIA-licensed molecular diagnostic facility. Our advanced instrumentation, including Illumina Miseq sequencers provides the industry’s most informative microbial diagnostics for ENT, microbiology laboratories, orthopedic, urology, wound care, podiatry, and other areas of medicine. Our laboratory is backed by a team of molecular biologists, biochemists, bioinformaticians, computer scientists, and physicians. MicroGenDX employs over 100 passionate employees lead by a leadership model designed to swiftly adapt to global health concerns to ensure our technology is used to help as many people as possible when it comes to microbial identification to help with tough to treat infections.

Ability to pivot
Immediate Action: Our Response to COVID-19

Within the first few weeks of the COVID-19 global pandemic, our team of specialists validated a real-time Reverse Transcriptase PCR (rRT-PCR) assay for the specific detection of the SARS-CoV-2 virus using saliva, sputum and nasal swabs. We increased laboratory capacity in response to the pandemic, allowing us to run over 10,000 samples a day. Our rapid COVID-19 PCR test is FDA EUA approved and has a 24-hour turnaround from time of sample receipt.

Our Continued Commitment of Laboratory Services

During this unprecedented time, we will continue to offer our normal PCR and Next Generation DNA Sequencing testing services in the areas of ENT/AFB, Pulmonary, ExPlants, Microbiology Lab services, Oral, Orthopedic, Podiatry/Nail, Urology, OB/GYN and Wound Care for infectious disease detection.

Health care practitioners, contact us today to discuss how molecular diagnostics provided by MicroGenDX® can bring your practice to the forefront of technological advancement, remove the guesswork of microbes with the infection site, and assistance with targeted treatment options.

Accredited, Highly Reliable, and Fast Molecular Diagnostics Tailored for Your Practice Needs


Testing Options

Next-Gen DNA Sequencing molecular microbial diagnostic tests are offered at MicroGenDX®. In our process analysis of the microbial DNA is extracted from the patient's swab, washing, or tissue sample. The microbial DNA is then analyzed using molecular diagnostic methods. The report contains information about the microbial organisms detected, gene resistance detected, and is accompanied with an Antimicrobial Recommendations Sheet.

Getting Started With MicroGenDX

Sample collection and shipping kits supplied by MicroGenDX® instill quality assurance in diagnostic results by following proper specimen management according to the American Society for Microbiology Guidelines in the following ways:

  1. Ensures that patient specimens are collected, transported, and stored properly
  2. Ensuring that the specimens arrive at the laboratory for analysis as quickly as possible
  3. Minimizes staff training by simplifying and standardizing collection materials
  4. Eliminates the need for clinic to stock perishable sampling supplies

The health care practitioner needs to decide what level of testing is necessary, and order kits to obtain sample collection and shipping supplies. Collect and ship patient samples with the MicroGenDX® sample collection kits, and ship it using the pre-paid FedEx Priority Overnight shipping labels we supply. Results are delivered within 24 hours for PCR Rapid Screening tests from time of receipt, and within 3-5 business days for NGS Level 2 test results.

Click Below to View Additional Information

Facilities:

MicroGenDX Laboratory is located at 2002 West Loop 289 Suite 116 Lubbock TX, 79407. Our lab space is divided into a molecular core lab, a reagent lab, general laboratory space, and a Next Generation Sequencing infrastructure that includes all of the latest platforms for sequencing by synthesis; including a Roche Genome Sequencer FLX 454 pyrosequencer, a Roche Genome Sequencer FLX+ (plus) and the Illumina MiSeq personal Sequencer. We are committed by our effort to stay with up to date with world-class bioinstrumentation.

If you need a facilities statement, please contact our Research Division here.

Licenses

Southwest Regional PCR Laboratory LLC dba MicroGenDX® Laboratory is a CAP accredited, CLIA licensed clinical diagnostic laboratory providing physicians and their patients with the most advanced molecular based microbial testing available. The laboratory utilizes molecular diagnostics and specializes in Next Generation DNA Sequencing technologies to identify pathogenic microbes within patient samples. MicroGenDX® is currently licensed to provide these services in 49 of the 50 states, with New York being the exception. Most states do not require additional licensure beyond CAP accreditation and CLIA licensing.

Click links below to see current images of our licenses, or contact us with specific questions regarding your location.

California State License

Maryland State License

Maryland State License

Pennsylvania State License

Pennsylvania State License

Rhode Island State License

Rhode Island State License

Click Below to View Additional Information

Mission Statement:
At MicroGenDX®, it is our mission to provide clinicians and their patients with the most informative microbial diagnostic tests that science can afford. This requires the use of the cutting edge scientific instrumentation and a team of molecular biologists, biochemists, bioinformaticians, computer scientists, and physicians. We are a state-of-the-art CAP accredited, CLIA licensed Molecular Diagnostic Facility.
Statement of Ethics:
At MicroGenDX®, we believe that molecular diagnostic services require continuous attention to professional ethics. Although the clinical laboratory focus remains primarily on pathogen detection, we take our contribution to genomic medicine very seriously. We are committed to respecting the confidential nature of all patient information, only disclosing personal health information with individual consent, and where there is a legal and ethical duty to disclose. We will maintain confidentiality in creating, storing, accessing, transferring, and disposing of personal health information. MicroGenDX® has worked with Western Institutional Review Board, and works closely with customer IRB's to address ethical issues relating to human subjects research.
Facilities:

MicroGenDX® is located on the Southeast corner of Marsha Sharp Freeway and Quaker Ave. in Lubbock, TX. Our lab space is divided into a molecular core lab, a reagent lab, general laboratory space, and a Next Generation Sequencing infrastructure that includes all of the latest platforms for sequencing by synthesis; including a Roche Genome Sequencer FLX 454 pyrosequencer, a Roche Genome Sequencer FLX+ (plus) 454 pyrosequencer, two Life Technologies Ion Torrent Personal Genome Machines, Ion Torrent Proton semiconductor sequencing machines, and the Illumina MiSeq personal Sequencer. We are committed by our effort to stay with up to date with world-class bioinstrumentation.

If you need a facilities statement, please contact our Research Division here.

Licenses

Southwest Regional PCR Laboratory LLC dba MicroGenDX® Laboratory is a CAP accredited, CLIA licensed clinical diagnostic laboratory providing physicians and their patients with the most advanced molecular based microbial testing available. The laboratory utilizes molecular diagnostics and specializes in next generation DNA sequencing technologies to identify pathogenic microbes within patient samples. MicroGenDX® is currently licensed to provide these services in 49 of the 50 states, with New York being the exception. Most states do not require additional licensure beyond CAP accreditation and CLIA licensing.

Click links below to see current images of our licenses, or contact us with specific questions regarding your location.

California State License

California State License

Florida State License

Florida State License

Maryland State License

Maryland State License

Pennsylvania State License

Pennsylvania State License

Rhode Island State License

Rhode Island State License

Translate »
Shopping Cart
There are no products in the cart!
Subtotal
$0.00
Total
$0.00
Continue Shopping
0